Nicergoline
C04A - Peripheral vasodilators
ATC C04AE02
Small molecule
Natural product
JFDA label: SERMION Tab
Indications
Approved
- Cardiovascular Diseases — cardiovascular disease
Off-label
- Anxiety
- Deglutition Disorders
- Dementia
- Depressive Disorder
- Schizophrenia
Chemistry & Properties
| Formula | C24H26BrN3O3 |
| Molecular weight | 484.39 g/mol |
| IUPAC name | [(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6H-indolo[4,3-fg]quinolin-9-yl]methyl 5-bromopyridine-3-carboxylate |
| CAS | 27848-84-6 |
| PubChem CID | 34040 |
| InChIKey | YSEXMKHXIOCEJA-FVFQAYNVSA-N |
| logP | 3.91 (XLogP 3.2) |
| Polar surface area | 56.59 Ų |
| H-bond acceptors / donors | 6 / 0 |
| Drug-likeness (QED) | 0.53 |
| Lipinski violations | 0 |
SMILES
CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13
Biology & Pharmacokinetics
Pharmacokinetics
Enzyme interactions
| Enzyme | Role | Detail |
| CYP1A2 | Inhibitor |
— |
| CYP1A2 | Substrate |
— |
| CYP2B6 | Inhibitor |
— |
| CYP2C19 | Inhibitor |
— |
| CYP2C8 | Inhibitor |
— |
| CYP2D6 | Inhibitor |
— |
| CYP2D6 | Substrate |
— |
| CYP3A4 | Inhibitor |
— |
| CYP3A4 | Substrate |
— |
Transporters
BCRP (Inhibitor)BSEP (Inhibitor)MRP1 (Inhibitor)OATP1B1 (Inhibitor)OATP1B1 (Inhibitor)OATP1B3 (Inhibitor)OATP1B3 (Inhibitor)P-gp (Inhibitor)P-gp (Substrate)
Registered Products (1)
| Brand | Form / strength | Pack | Agent | Citizen (JOD) |
| SERMION Tab
|
Tablet 5 mg |
30 tab |
Khoury Drug Store |
2.300 |